Acamprosate Calcium
Product Images NDC 10135-636

2 FDA label images from Marlex Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 10135-636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Acamprosate Calcium. (Acamprosate Calcium Tablets 01)

The Structural Formula Of Acamprosate Calcium. (Acamprosate Calcium Tablets 01)
Chemical structure of Acamprosate Calcium depicting the molecular arrangement including an acetyl group, amide linkage, sulfonate group, and calcium ion complexation.*
FDA Label Image

Ndc 10135-0636-32acamprosate Calciumdelayed-releasetablets333 mgrx Only180 Tablets (Acamprosate Calcium Tablets 02)

Ndc 10135-0636-32acamprosate Calciumdelayed-releasetablets333 mgrx Only180 Tablets (Acamprosate Calcium Tablets 02)
Acamprosate Calcium Delayed-Release Tablets, 333 mg, by Marlex Pharmaceuticals Inc. The label indicates 180 tablets per container. It includes storage instructions and a barcode. The product is Rx only and manufactured and distributed by Marlex Pharmaceuticals, Inc., New Castle, DE.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.